Lucid Diagnostics Inc.
LUCD
$1.20
-$0.01-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.57% | 12.93% | 3.30% | 34.68% | 27.45% |
| Total Depreciation and Amortization | -64.71% | -65.60% | -63.82% | -18.14% | 2.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.78% | -50.69% | 6.71% | -85.72% | -89.33% |
| Change in Net Operating Assets | 574.63% | -127.63% | -171.44% | -223.68% | -103.30% |
| Cash from Operations | 1.08% | -15.88% | -65.52% | -77.13% | -134.36% |
| Capital Expenditure | -48.00% | 100.00% | 100.00% | -117.65% | 13.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -48.00% | -2,400.00% | 100.00% | -117.65% | 13.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -65.82% | -- | -36.25% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | 33.32% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 259.98% | -65.82% | -- | -23.42% | 499,900.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 252.68% | -22.43% | 102.17% | -65.55% | -15.56% |